Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06655857 · ClinicalTrials.gov registry record · NA
Interventions for Promoting Kidney Transplant Empowerment
A NA study of Kidney Transplant Waitlisting, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 3
- Study locations
NCT06655857: Recruiting NA study of Kidney Transplant Waitlisting, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06655857 is a NA study of Kidney Transplant Waitlisting that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06655857, a NA study of Kidney Transplant Waitlisting, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a cluster randomized controlled clinical trial evaluating the effect of community health workers (CHWs) and provider education on kidney transplant (KTx) waitlisting compared to usual care (waitlist control). CKD/HD providers will be randomized to intervention or control, and all patients with the same providers will be in the same randomization group. CHWs will address unmet social needs and patient symptoms through evaluations and linkage to clinical and community services. Intervention providers will receive education, which will include training on working with CHWs, reducing bias in clinical decision-making, and increasing affirming/reducing stigmatizing language in electronic health records (EHRs).
Primary Outcome
Patient medical records will be reviewed, and the patient will be asked directly for the status of their kidney transplant evaluation.
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER Community Health Worker Assistance
- OTHER Intervention Providers
Study Locations (3)
New York
- NYU Langone Health - New York
- Mount Sinai Hospital - New York
- Montefiore Einstein - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-08-05 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT06655857 shows while recruiting
NCT06655857 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Kidney Transplant Waitlisting appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.
NCT06655857 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06655857 about?
NCT06655857 is a clinical study titled "Interventions for Promoting Kidney Transplant Empowerment". This is a cluster randomized controlled clinical trial evaluating the effect of community health workers (CHWs) and provider education on kidney transplant (KTx) waitlisting compared to usual care (waitlist control). CKD/HD providers will be randomized to intervention or control, and all patients wi...
What is the current status of trial NCT06655857?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2025-08-05. Estimated completion is 2026-03-31.
What conditions does trial NCT06655857 study?
This clinical trial studies the following conditions: Kidney Transplant Waitlisting.
What interventions are being tested in trial NCT06655857?
The interventions under investigation include: Usual Care (OTHER), Community Health Worker Assistance (OTHER), Intervention Providers (OTHER).
Who is sponsoring clinical trial NCT06655857?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06655857 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06655857's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI